|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||20.41 - 21.18|
|52 Week Range||7.37 - 28.66|
|Beta (5Y Monthly)||1.65|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Today we will run through one way of estimating the intrinsic value of MEDNAX, Inc. (NYSE:MD) by projecting its future...
MEDNAX's (MD) third-quarter results reflect muted revenues and high costs, partly offset by lower interest expense.
MD earnings call for the period ending October 30, 2020.